HCP Live
Contagion LiveCGT LiveNeurology LiveHCP LiveOncology LiveContemporary PediatricsContemporary OBGYNEndocrinology NetworkPractical CardiologyRheumatology Netowrk

Women's Health


Risk of Pregnancy Complications Greater in Women with Systemic Lupus Erythematosus

June 18, 2022

Data from an analysis of the National Inpatient Sample provides insight into the risk of pregnancy complications among women with systemic lupus erythematosus compared to their counterparts without systemic lupus erythematosus in the US over a decade-long period.

Systemic Sclerosis Increases Risk of Adverse Pregnancy Outcomes

April 28, 2022

“In recent years, the habit of delaying pregnancy because of social and economic reasons has become more common, increasing the possibility of getting pregnant after the onset of the disease," investigators stated. "This fact makes pregnancy a more frequent issue to deal with in the present years.”

Low Prevalence of Anti-SSA/B in Women With Rheumatoid Arthritis Wishing to Conceive

July 15, 2021

Given the low prevalence of anti-Sjögren's-syndrome-related antigen A (anti-SSA) and anti–Sjögren's-syndrome-related antigen B (anti-SSB) in women with rheumatoid arthritis who would like to conceive, intensive echocardiographic screening may not be necessary.

Women's Health and Osteoporosis Studies That Should Be on Your Radar

November 20, 2020

Over the course of this year there have been some pivotal studies on osteoporosis and women's health. We've published stories based on studies that explore the use of vitamin D and calcium supplementation and bone mineral density. We've featured a few studies that examine the effectiveness of bisphosphonates and the role of anabolic agents to to fight osteoporosis. Learn more about these and other studies in today's slideshow.

Treatment Sequence Matters in Osteoporosis

November 18, 2020

Osteoporosis therapeutic treatments should always be individualized, says Felicia Cosman, M.D., an endocrinologist with Columbia University College of Physicians and Surgeons in New York. Dr. Cosman is the author of a study recently presented at the American College of Rheumatology annual meeting in which she shared results from a study that explored treatment sequences with romosozumab before or after antiresorptive medication.